No improvement in freedom from progression rates for patients: Study

FHS
June 16, 2023
4:19 am

Results from the NRG Oncology NRG-RTOG 0232 clinical trial adding external beam radiotherapy (EBRT) to brachytherapy (BT) in men with intermediate-risk prostate cancer indicate that there was no improvement in freedom from progression (FFP) rates for patients.

A global look at the gut: Scientists highlight microbiome diversity

Researchers analyzed 168,464 samples to uncover how geographic and technical factors shape global gut microbiome variation, highlighting underrepresented regions and technical biases.

January 24, 2025

Hospitals race to adopt generative AI, even as regulators struggle to keep up with the risks

Usually the words generative AI in health are followed by a bold claim. The technology will transform some aspect of care delivery, save gobs of

February 21, 2024

New research underscores benefits of gender-affirming hormones, rebutting anti-trans claims

Anti-trans legislation and rhetoric frequently suggest that taking gender-affirming hormones is a big health risk. But at the annual meeting of the Endocrine Society last

June 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.